大麻使用与精神病起病年龄提前的年龄相关性加速:一项荟萃分析
该荟萃分析纳入149项研究、181个样本,比较大麻使用者与非使用者的精神病平均起病年龄。大麻使用与起病年龄平均提前2.50年相关,且该效应随样本平均起病年龄增大而增大,≥30岁组提前达6.30年。
要点
- 大麻使用者精神病起病年龄平均提前2.50年。
- 起病年龄<20岁组无显著差异,≥30岁组提前6.30年。
- 样本平均起病年龄是效应量的独立调节因素。
核心结论
- 大麻使用与精神病起病年龄提前的关联稳健,且样本平均起病年龄越大效应量越大。
研究设计与样本
- 检索MEDLINE、Embase和PsycInfo至2025年4月,纳入报告大麻使用者与非使用者精神病起病年龄均值与标准差的同行评议队列和病例对照研究。
- 采用随机效应荟萃分析计算合并标准化均数差,亚组分析用混合效应模型,异质性用随机效应元回归检验。
主要发现
- 主荟萃分析纳入149项研究的181个样本,含18,272名大麻使用者和52,801名非使用者。
- 大麻使用与精神病起病年龄平均提前2.50年相关。
- 按样本平均起病年龄亚组分析:<20岁组无差异;20至<25岁组提前1.60年;25至<30岁组提前4.43年;≥30岁组提前6.30年。
- 元回归显示样本平均起病年龄是提前效应量的强独立调节因素(z = -7.59, p < .0001)。
临床怎么用
- 临床评估精神病风险时应询问大麻使用情况,尤其对起病年龄较晚者需关注大麻使用的潜在影响。
- 支持考虑开展全生命周期大麻使用相关精神健康风险的公共卫生警示。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Increases in cannabis use, potency, and legal liberalization have raised concerns about psychiatric consequences. Previous studies suggest an association between cannabis use and earlier age at onset (AAO) of psychosis, but an updated meta-analysis is needed. METHODS: MEDLINE, Embase, and PsycInfo were searched from inception to April 2025. Peer-reviewed cohort and case-control studies reporting mean and standard deviation of AAO of psychosis in cannabis users and nonusers or other effect size data were included. Pooled standardized mean difference was calculated using random-effects meta-analysis. Subgroup analyses used mixed effects models, and between-study heterogeneity was examined with random-effects meta-regression. RESULTS: The main meta-analysis included 181 samples from 149 studies, comprising 18,272 cannabis users and 52,801 nonusers. Cannabis use was associated with a mean earlier AAO of 2.50 years. Subgroup analysis by sample mean onset age found no difference in AAO of psychosis between cannabis users and nonusers in the <20-year-old group, but there was a progressive age-related difference; cannabis users in the 20 to <25, 25 to <30, and ≥30 groups had an earlier AAO of 1.60, 4.43, and 6.30 years, respectively. Multiple meta-regression indicated that sample mean onset age was a strong and statistically independent moderator of earlier AAO effect size (z = -7.59, p < .0001). CONCLUSIONS: The association between cannabis use and earlier psychosis onset is robust, with larger effect sizes in samples with later mean age of psychosis onset. These findings support consideration of public health warnings of the potential psychiatric risks associated with cannabis use across the lifespan.
引用
- Stevens C, Pincham H, Large M, et al. Cannabis Use and Age-Related Acceleration of Psychosis Onset: A Meta-Analysis. Biol Psychiatry. 2026. PMID: 42610992. doi:10.1016/j.biopsych.2026.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。